Researchers developed the seats to measure biometrics during ‘natural’ processes
With 1 million new cases of congestive heart failure diagnosed each year, a revolutionary product is making it easier for hospitals to monitor patients with the condition in the comfort of their own homes.
A toilet-seat based cardiovascular monitoring system created by a team of Rochester Institute of Technology researchers, aims to lower the hospital readmission rates of patients with congestive heart failure. The toilet seats, which will be brought through the FDA clearance process by the researchers’ company Heart Health Intelligence, would be purchased by hospitals and issued to heart failure patients after discharge. The toilet seats are equipped to measure the electrical and mechanical activity of the heart, and can monitor heart rate, blood pressure, blood oxygenation levels, and the patient’s weight and stroke volume, which is the amount of blood pumped out of the heart at every beat. Algorithms analyze the data, and with further development, will alert advanced practice providers of a deteriorating condition. A report will be passed along to cardiologists who will then determine if intervention is necessary.
Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that developed the toilet seats.
“Typically, within 30 days of hospital discharge, 25 percent of patients with congestive heart failure are readmitted,” said Conn. “After 90 days of hospital discharge, 45 percent of patients are readmitted. And the Centers for Medicare and Medicaid Services is penalizing hospitals for readmitting patients for heart failure.”
Conn, the company’s chief executive officer, further explains that using the national average for readmission rates, the penalty alone for readmitting 150 patients is approximately $500,000 annually. The total cost of providing 150 patients with their own monitored toilet seats from HHI is $200,000. With that investment, he says, hospital systems will save more than double their initial investment within one year.
According to Conn, who earned three degrees from RIT—a bachelor’s degree and a master’s degree in electrical engineering in 2011 and 2013, respectively, and a doctoral degree in microsystems engineering in 2016—the system will pick up deteriorating conditions before the patients even realize they are symptomatic. And with the rapid data analysis, interventions can be as simple as a drug change or short office visit, instead of an admission to the hospital.
HHI, which joined RIT’s Venture Creations business incubator earlier this year, is now focused on moving the product forward. The team is heavily involved in writing grants for additional funding and networking, and human-subject testing and pre-clinical studies are well underway. Conn and his team are working on approving the product with the FDA and rolling it out across the country.
The Latest on: Congestive heart failure
via Google News
The Latest on: Congestive heart failure
- Alcoholic Cardiomyopathy: Drinking Too Much In Winter Can Lead To Heart Failureon December 3, 2021 at 9:58 pm
People who consume too much alcohol during winter to keep themselves warm are actually putting themselves at risk of heart failure, warn doctors.
- Cleats designed by 10-year-old heart transplant patient on display during Falcons' gameon December 3, 2021 at 11:28 am
Keep your eyes peeled during Sunday's Atlanta Falcons' game for special cleats designed by 10-year-old Bentley Nation.
- Global Congestive Heart Failure (CHF) Market Insights, Epidemiology and Market Forecast to 2030 - ResearchAndMarkets.comon December 3, 2021 at 7:54 am
Market Insights, Epidemiology and Market Forecast - 2030” report has been added to ResearchAndMarkets.com’s offering. The Congestive Heart Failure (CHF) market report provides current treatment ...
- An Obscure Agency Is Threatening to Hand Medicare Over to Wall Streeton December 3, 2021 at 7:09 am
30 million seniors who thought they were free of insurance companies may find their health care managed by corporations.
- Drinking Excess Alcohol in Winter Season Can be Harmful to Your Heart: Studyon December 3, 2021 at 3:56 am
Alcoholic cardiomyopathy is commonly seen in men between the ages of 35 and 50, but the condition can affect women as well ...
- On This Day, World's First Artificial Heart Was Successfully Implanted Into Human Bodyon December 2, 2021 at 8:43 am
Willem Johan Kolff, the world's most creative inventor of artificial organs, implanted the artificial heart into Barney Clark, a dentist from Seattle suffering from ...
- Global Congestive Heart Failure Clinical Trial Pipeline Market Report 2021 - ResearchAndMarkets.comon December 2, 2021 at 7:27 am
The "Global Congestive Heart Failure Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
- Restore Medical kick-starts clinical trial for Contraband cardiac implanton December 1, 2021 at 4:00 pm
Restore Medical Ltd. is implanting the first patients with its Contraband technology for congestive heart failure (CHF). The minimally invasive, catheter-delivered implant is being assessed in ...
- It’s time to exam your hearton December 1, 2021 at 3:34 pm
When the heart stops beating, humans begin to die. If it does not recover, death is inevitable. You cannot live without a beating heart. My mother died six years ago from congestive heart failure, a ...
- United States Congestive Heart Failure Market and Competitive Landscape Report 2021 - ResearchAndMarkets.comon December 1, 2021 at 8:44 am
The "US Congestive Heart Failure Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
via Bing News